Inflammatory Mediators and Cytokine Signaling

Inflammation is the coordinated host response to infection and tissue damage, orchestrated largely by cytokines and other soluble mediators. These signaling molecules act locally and systemically to recruit leukocytes, alter vascular tone and permeability, and instruct the magnitude and character of both innate and adaptive immune responses.

Definition

Cytokines are small secreted proteins that act as intercellular messengers, binding specific receptors to regulate the growth, differentiation, recruitment, and activation of immune and other cells; inflammation is the integrated tissue response they coordinate in reaction to infection or damage.

Scope

This topic covers the cardinal features of inflammation, the major proinflammatory cytokine families and their signaling, the inflammasome as a platform for IL-1 family activation, and the counter-regulatory mediators that resolve inflammation. It treats inflammation as a mechanistic topic in innate immunity and is not clinical guidance.

Core questions

• How are inflammatory programs triggered by microbial and damage signals?
• Which cytokine families drive, amplify, and resolve inflammation?
• How do inflammasomes convert sensing into mature IL-1 family cytokine release?
• How is inflammation resolved to limit collateral tissue injury?

Key concepts

• Cardinal signs of inflammation
• Proinflammatory cytokines (TNF, IL-1, IL-6)
• Type I and type II interferons
• Chemokines and leukocyte recruitment
• Inflammasome and IL-1 maturation
• Acute-phase response
• Anti-inflammatory and pro-resolution mediators (IL-10)
• Sterile versus infectious inflammation

Mechanisms

Engagement of pattern-recognition receptors by microbial or damage signals activates transcription factors such as NF-kappaB, inducing proinflammatory cytokines including TNF, IL-1, and IL-6 along with chemokines that recruit leukocytes. Cytokines act through receptor-coupled signaling cascades, including the JAK-STAT pathway for many interferons and interleukins, to reprogram target cells. The inflammasome, a cytosolic multiprotein complex, activates caspase-1 to cleave pro-IL-1-beta and pro-IL-18 into their active forms, providing a second checkpoint between sensing and secretion. The response is countered by anti-inflammatory and pro-resolution mediators, such as IL-10, that restrain cytokine production and promote return to homeostasis, balancing host defense against tissue injury.

Clinical relevance

Cytokine biology underlies fever and the acute-phase response, the pathophysiology of sepsis and cytokine-release states, chronic inflammatory and autoinflammatory disease, and the rationale for cytokine-targeted biologic therapies. This entry describes mechanisms for reference and is not a basis for individual diagnosis or treatment.

Evidence & guidelines

Descriptions reflect established reviews of inflammation and cytokine signaling rather than quantitative clinical evidence or practice guidelines.

History

Inflammation's cardinal signs were described in antiquity, but its molecular basis emerged in the twentieth century with the identification of cytokines such as the interferons, tumor necrosis factor, and the interleukins. The discovery of the inflammasome in the 2000s clarified how danger sensing is coupled to IL-1 family cytokine maturation, integrating inflammation with the broader innate sensing apparatus.

Key figures

• Charles Janeway
• Jurg Tschopp
• Shizuo Akira
• Bharat Aggarwal

Seminal works

• takeuchi-2010
• schroder-2010
• chen-2010

Frequently asked questions

What is the difference between a cytokine and a chemokine?

Chemokines are a structurally defined subset of cytokines whose principal function is to direct the migration of leukocytes along concentration gradients. The broader cytokine category also includes mediators that regulate cell growth, differentiation, and activation rather than chemotaxis.

What does the inflammasome do?

The inflammasome is a cytosolic protein complex that, upon sensing certain microbial or danger signals, activates caspase-1 to convert precursor IL-1-beta and IL-18 into their active secreted forms, providing a controlled trigger for potent inflammatory signaling.